Paris-based Cooper Consumer Health is set to be acquired by private equity firm CVC, which has been following the growing firm's progress "for many years."
Cooper Consumer Health looks set to change hands after finding new private equity backers.
Owner Charterhouse Capital has entered into exclusive negotiations to sell a majority stake in European OTC and dietary supplements player Cooper to a fund controlled by CVC Capital Partners
Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.
Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.
Swedish producer of antioxidant astaxanthin AstaReal has expanded its product offering with cardiovascular health focused-brand Kyolic.
Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.
